MEDS
NASDAQDataMEDS AI
$3.40
+0.52 (+18.06%)
Income Statement
Total Revenue
In Millions USDNet Income
In Millions USDProfit Margins
Gross
Operating
Net
Detailed Income Statement
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Revenue | $23M | $18M | - | $33M |
| Cost of Revenue | $33M | $16M | - | $27M |
| Gross Profit | $-10M | $2M | - | $6M |
| Operating Expenses | - | - | - | - |
| Operating Income | $-81M | $-6M | $-3M | $-3M |
| Net Income | $-101M | $-7M | $-3M | $-3M |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | $0.00 |
Balance Sheet
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & Equivalents | $43K | $1M | $1K | - |
| Total Assets | $30M | $57M | $338K | - |
| Total Liabilities | $43M | $51M | $3M | $5K |
| Total Debt | $24M | $24M | $700K | - |
| Shareholders Equity | $-12M | $7M | $-3M | $-5K |
Cash Flow Statement
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating Cash Flow | $-11M | $-1M | $-349K | - |
| Investing Cash Flow | $-882K | $469K | - | - |
| Financing Cash Flow | $11M | $2M | $350K | - |
| Capital Expenditures | $882K | $377K | - | - |
| Free Cash Flow | $-12M | $-2M | $-349K | - |